Published in Diabetes Care on March 01, 2006
Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young. Diabetes Care (2011) 1.86
Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care (2011) 1.30
The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients. Diabetes Care (2013) 1.23
Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes. Diabetes Care (2010) 1.10
Metabolic regulation in progression to autoimmune diabetes. PLoS Comput Biol (2011) 1.06
The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes. Diabetes Care (2012) 1.03
Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals. Ann N Y Acad Sci (2013) 1.02
Effects of non-HLA gene polymorphisms on development of islet autoimmunity and type 1 diabetes in a population with high-risk HLA-DR,DQ genotypes. Diabetes (2012) 1.01
Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY). Diabetes Care (2015) 1.01
The interplay of autoimmunity and insulin resistance in type 1 diabetes. Discov Med (2012) 0.96
Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis. Diabetes Care (2012) 0.96
Reappraising the stereotypes of diabetes in the modern diabetogenic environment. Nat Rev Endocrinol (2009) 0.91
Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1). Diabetes (2010) 0.89
The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1. Diabetes (2012) 0.88
Established and emerging biomarkers for the prediction of type 1 diabetes: a systematic review. Transl Res (2014) 0.87
Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers. Pediatr Diabetes (2013) 0.85
Antibodies against insulin measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes status. J Transl Med (2011) 0.85
Assessing generalisability through the use of disease registers: findings from a diabetes cohort study. BMJ Open (2011) 0.85
Mass spectrometric determination of IgG subclass-specific glycosylation profiles in siblings discordant for myositis syndromes. J Proteome Res (2011) 0.84
Type 1 diabetes: primary antigen/peptide/register/trimolecular complex. Immunol Res (2013) 0.81
Staging the progression to type 1 diabetes with prediagnostic markers. Curr Opin Endocrinol Diabetes Obes (2016) 0.77
A rule-based prognostic model for type 1 diabetes by identifying and synthesizing baseline profile patterns. PLoS One (2014) 0.75
Growth and Risk for Islet Autoimmunity and Progression to Type 1 Diabetes in Early Childhood: The Environmental Determinants of Diabetes in the Young Study. Diabetes (2016) 0.75
Early prediction of autoimmune (type 1) diabetes. Diabetologia (2017) 0.75
Joint modeling of longitudinal autoantibody patterns and progression to type 1 diabetes: results from the TEDDY study. Acta Diabetol (2017) 0.75
Prevalence of Celiac disease among children in Finland. N Engl J Med (2003) 7.27
Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA (2003) 6.60
Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med (2010) 4.16
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA (2013) 3.65
Toward defining the autoimmune microbiome for type 1 diabetes. ISME J (2010) 3.03
Environmental triggers and determinants of type 1 diabetes. Diabetes (2005) 2.93
Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J Exp Med (2008) 2.79
Cohort profile: the cardiovascular risk in Young Finns Study. Int J Epidemiol (2008) 2.51
Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes (2012) 2.22
Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One (2011) 2.18
Back, neck, and shoulder pain in Finnish adolescents: national cross sectional surveys. BMJ (2002) 1.90
Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility. Scand J Gastroenterol (2005) 1.85
Nutritional risk predictors of beta cell autoimmunity and type 1 diabetes at a young age. Am J Clin Nutr (2003) 1.76
Serological evidence of thyroid autoimmunity among schoolchildren in two different socioeconomic environments. J Clin Endocrinol Metab (2007) 1.68
Association of human bocavirus 1 infection with respiratory disease in childhood follow-up study, Finland. Emerg Infect Dis (2012) 1.67
IL-17 immunity in human type 1 diabetes. J Immunol (2010) 1.67
Prediction of type 1 diabetes in the general population. Diabetes Care (2010) 1.66
Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial. J Pediatr (2003) 1.64
Timing of infant feeding in relation to childhood asthma and allergic diseases. J Allergy Clin Immunol (2012) 1.62
Serum insulin and leptin levels in valproate-associated obesity. Epilepsia (2002) 1.60
Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population. Diabetes (2009) 1.59
Effectiveness of dynamic muscle training, relaxation training, or ordinary activity for chronic neck pain: randomised controlled trial. BMJ (2003) 1.58
Parental reactions to information about increased genetic risk of type 1 diabetes mellitus in infants. Arch Pediatr Adolesc Med (2006) 1.55
Childhood malnutrition and its predictors in rural Malawi. Paediatr Perinat Epidemiol (2003) 1.51
Vitamin D receptor polymorphisms: no association with type 1 diabetes in the Finnish population. Eur J Endocrinol (2003) 1.49
Infant feeding and the risk of type 1 diabetes. Am J Clin Nutr (2010) 1.47
Prevalence and fate of type 1 diabetes-associated autoantibodies in cord blood samples from newborn infants of non-diabetic mothers. Diabetes Metab Res Rev (2002) 1.47
Cord serum lipidome in prediction of islet autoimmunity and type 1 diabetes. Diabetes (2013) 1.47
Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis (2004) 1.45
Lower economic status and inferior hygienic environment may protect against celiac disease. Ann Med (2008) 1.39
Perinatal factors and the risk of asthma in childhood--a population-based register study in Finland. Am J Epidemiol (2008) 1.34
Coxsackievirus B1 is associated with induction of β-cell autoimmunity that portends type 1 diabetes. Diabetes (2013) 1.34
Environmental factors in the etiology of type 1 diabetes. Am J Med Genet (2002) 1.33
Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes. Diabetes (2013) 1.30
Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract (2002) 1.28
Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol (2003) 1.28
Ketoacidosis at diagnosis of type 1 diabetes in children in northern Finland: temporal changes over 20 years. Diabetes Care (2007) 1.27
Enterovirus RNA in blood is linked to the development of type 1 diabetes. Diabetes (2010) 1.26
GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. J Autoimmun (2005) 1.26
Missing values in longitudinal dietary data: a multiple imputation approach based on a fully conditional specification. Stat Med (2009) 1.25
A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: an application for the TEDDY (the Environmental Determinants of Diabetes in the Young) study. Diabetes Technol Ther (2007) 1.23
Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J Med Virol (2003) 1.22
New Finnish growth references for children and adolescents aged 0 to 20 years: Length/height-for-age, weight-for-length/height, and body mass index-for-age. Ann Med (2010) 1.22
Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia (2009) 1.19
Associations of dietary fiber with glucose metabolism in nondiabetic relatives of subjects with type 2 diabetes: the Botnia Dietary Study. Diabetes Care (2003) 1.18
Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: predictive role of autoantibodies. Diabetes Care (2006) 1.16
Dietary intakes and plasma concentrations of carotenoids and tocopherols in relation to glucose metabolism in subjects at high risk of type 2 diabetes: the Botnia Dietary Study. Am J Clin Nutr (2003) 1.16
Incidence of type 1 diabetes in Finland. JAMA (2013) 1.15
Advanced glycation end products are direct modulators of β-cell function. Diabetes (2011) 1.14
Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. J Autoimmun (2008) 1.13
Dietary intake and use of dietary supplements in relation to demographic variables among pregnant Finnish women. Br J Nutr (2006) 1.12
Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care (2011) 1.11
Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes. Am J Med Genet (2002) 1.10
Age at the introduction of solid foods during the first year and allergic sensitization at age 5 years. Pediatrics (2009) 1.10
Genetic risk determines the emergence of diabetes-associated autoantibodies in young children. Diabetes (2002) 1.10
Other complications and associated conditions with diabetes in children and adolescents. Pediatr Diabetes (2009) 1.07
New population-based references for birth weight, length, and head circumference in singletons and twins from 23 to 43 gestation weeks. Ann Med (2013) 1.07
Maternal antibodies in breast milk protect the child from enterovirus infections. Pediatrics (2007) 1.07
Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes (2010) 1.06
Metabolic regulation in progression to autoimmune diabetes. PLoS Comput Biol (2011) 1.06
Development of a model for optimal food fortification: vitamin D among adults in Finland. Eur J Nutr (2007) 1.06
Estimation of genetic risk for type 1 diabetes. Am J Med Genet (2002) 1.06
Measurement of outpatients' views of service quality in a Finnish university hospital. J Adv Nurs (2002) 1.05
Intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the HLA-DQB1*02 allele. Autoimmunity (2002) 1.04
Age-related differences in the frequency of ketoacidosis at diagnosis of type 1 diabetes in children and adolescents. Diabetes Care (2010) 1.04
Human parechovirus 1 infections in young children--no association with type 1 diabetes. J Med Virol (2007) 1.04
Detection of autoantibodies to protein tyrosine phosphatase-like protein IA-2 with a novel time-resolved fluorimetric assay. Clin Chem (2003) 1.03
Human parechoviruses are frequently detected in stool of healthy Finnish children. J Clin Virol (2012) 1.02
Growth and biochemical markers of growth in children with snoring and obstructive sleep apnea. Pediatrics (2002) 1.02
A new table for work with a microscope, a solution to ergonomic problems. Appl Ergon (2003) 1.02
Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections. N Engl J Med (2015) 1.02
Should we screen for risk of type 1 diabetes? Diabetes Care (2008) 1.01
Associates of obesity and weight dissatisfaction among Finnish adolescents. Public Health Nutr (2003) 1.01
Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes. Eur J Endocrinol (2008) 1.01
Breastfeeding patterns of mothers with type 1 diabetes: results from an infant feeding trial. Diabetes Metab Res Rev (2010) 1.01
Fear and anxiety in patients at different time-points in the coronary artery bypass process. Int J Nurs Stud (2002) 1.01
Removal of Bovine Insulin From Cow's Milk Formula and Early Initiation of Beta-Cell Autoimmunity in the FINDIA Pilot Study. Arch Pediatr Adolesc Med (2012) 1.01
Sociodemographic factors and a secular trend of adolescent overweight in Finland. Int J Pediatr Obes (2009) 1.00
A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland. Ann Med (2005) 1.00